Новости о Trial Vaccine [ Фото новости ] [ Свежие новости ] | |
Markets Spike as Coronavirus Vaccine Trial Shows 90% Success Rate
Bitcoin and U.S. stock futures shot up on Monday after Pfizer announced positive results from a trial of its coronavirus vaccine. дальше »
2020-11-9 16:38 | |
|
JNJ Stock Up 1%, Johnson & Johnson Begins Final Trial of One-Shot Coronavirus Vaccine
Coinspeaker JNJ Stock Up 1%, Johnson & Johnson Begins Final Trial of One-Shot Coronavirus VaccineJohnson & Johnson has commenced a phase 3 trial of its one-shot vaccine. The company will recruit a total of 60,000 participants. дальше »
2020-9-23 17:25 | |
|
|
Pharmaceutical Giant AstraZeneca Resumes Clinical Trials for COVID-19 Vaccine, AZN Stock Slightly Up
Coinspeaker Pharmaceutical Giant AstraZeneca Resumes Clinical Trials for COVID-19 Vaccine, AZN Stock Slightly UpIn partnership with U. K. 's Oxford University, AstraZeneca said that it will resume the phase three clinical trial for its COVID-19 vaccine contender AZD1222 since it got an approval from UK's Medicines Health Regulatory Authority. дальше »
2020-9-13 12:56 | |
|
|
Sanofi and GlaxoSmithKline Launch Trials for Their COVID-19 Protein-Based Vaccine
Coinspeaker Sanofi and GlaxoSmithKline Launch Trials for Their COVID-19 Protein-Based VaccineFrench drugmaker Sanofi and Britain’s GlaxoSmithKline revealed that they had started a clinical trial of their protein-based COVID-19 vaccine candidate, aimed at reaching the final testing stage by December. дальше »
2020-9-3 15:51 | |
|
|
JNJ Stock Up 0.45%, Johnson & Johnson to Conduct Coronavirus Vaccine Trial in September
Coinspeaker JNJ Stock Up 0. 45%, Johnson & Johnson to Conduct Coronavirus Vaccine Trial in SeptemberThis will be the largest ever test so far on the coronavirus vaccine by any pharmaceutical giant. дальше »
2020-8-21 14:03 | |
|
|
NVAX Stock Up 13%, Novavax Early Trial of COVID-19 Vaccine Shows Stellar Immune Response
Coinspeaker NVAX Stock Up 13%, Novavax Early Trial of COVID-19 Vaccine Shows Stellar Immune ResponseScientists have Novavax's vaccine results to be impressive and exemplary. If the company gets more leads going ahead, it promises of producing 100 million doses by the start of 2021. дальше »
2020-8-5 18:17 | |
|
|
SNG Stock Soars 470% as Synairgen Reports Promising COVID-19 Vaccine Trial Results
Coinspeaker SNG Stock Soars 470% as Synairgen Reports Promising COVID-19 Vaccine Trial ResultsFollowing the company's announcement about the success of its COVID-19 vaccine, Synairgen stock has increased significantly. дальше »
2020-7-21 14:36 | |
|
|
JNJ Stock Up 0.67% as Johnson & Johnson Wants to Begin Late-Stage COVID-19 Vaccine Trial in September
Coinspeaker JNJ Stock Up 0. 67% as Johnson & Johnson Wants to Begin Late-Stage COVID-19 Vaccine Trial in SeptemberJohnson & Johnson (JNJ) stock price is rising as the company is moving forward with its vaccine trials. дальше »
2020-7-17 14:33 | |
|
|
BioNTech (BNTX) Stock Down 2% though Company Receives Approval for COVID-19 Vaccine Trials
Coinspeaker BioNTech (BNTX) Stock Down 2% though Company Receives Approval for COVID-19 Vaccine TrialsShanghai Fosun Pharmaceutical Industrial Development received the acceptance notice of clinical trial application for the COVID-19 vaccine candidate BNT162b1 created by BioNTech. дальше »
2020-7-17 22:15 | |
|
|
Why Hasn’t Bitcoin Followed Stocks Rallying On Positive Vaccine Data?
Overnight, news broke that early trial human patients developed a “robust” immune response to a potential virus vaccine from Moderna. Stock futures soared over the news, and the stock market opened today higher as a result. дальше »
2020-7-16 18:00 | |
|
|
MRNA Stock Up 18% in Pre-market, Moderna Has Good News about Its Coronavirus Vaccine
Coinspeaker MRNA Stock Up 18% in Pre-market, Moderna Has Good News about Its Coronavirus VaccineModerna (MRNA) stock is up over 18% in the pre-market after adding 4. 54% yesterday. The spike is attributed to the announcement that the coronavirus vaccine trial demonstrated a robust immune response. дальше »
2020-7-15 12:00 | |
|
|
Dow Futures Fade Because Vaccine Won’t Stop Virus Second Wave
Stocks rallied yesterday on Moderna's Covid-19 vaccine trial breakthrough, but health experts say it won't arrive in time to prevent a second wave of the virus. The post Dow Futures Fade Because Vaccine Won’t Stop Virus Second Wave appeared first on CCN.com дальше »
2020-5-19 14:25 | |
|
|
Moderna (MRNA) Stock Rises 10% after FDA Approves mRNA-1273 Vaccine for Phase 2 Trial
Coinspeaker Moderna (MRNA) Stock Rises 10% after FDA Approves mRNA-1273 Vaccine for Phase 2 TrialPhase 2 trial of Moderna's coronavirus vaccine will shortly begin and enroll 600 participants. дальше »
2020-5-7 19:48 | |
|
|
MRNA Stock Up 1.32% Now, Moderna Proceeds for Phase 2 Testing of Coronavirus Vaccine
Coinspeaker MRNA Stock Up 1. 32% Now, Moderna Proceeds for Phase 2 Testing of Coronavirus VaccineModerna Inc proceeds ahead for the Phase 2 clinical trial of its vaccine to fight with the coronavirus. дальше »
2020-4-29 13:51 | |
|
|